Results 181 to 190 of about 208,667 (379)
A personalized nanovaccine combining PLGA‐encapsulated heat‐inactivated CVB3 and membranes from CVB3‐infected breast cancer cells stimulates potent antitumor immunity. It reduces immunosuppressive markers, enhances immune activation, and improves survival in vivo.
Amirhossein Bahreyni+6 more
wiley +1 more source
This review explores the transformative potential of lipid‐based nanoparticles (LNPs) in renal cell carcinoma (RCC) therapy. It systematically analyzes six LNP platforms‐from liposomes to hybrid nanoparticles‐highlighting their unique advantages in targeted drug delivery, resistance reversal, and immunomodulation.
Wei Yao+7 more
wiley +1 more source
Studies of Ulceration and Edema of the Lower Extremity by Lymphatic Cannulation
T. G. Blocker+6 more
openalex +2 more sources
On the relations of the lymphatics of the spinal cord [PDF]
Alexander Balmain Bruce, James Dawson
openalex +1 more source
Venous thromboembolism (VTE) is a major threat to cancer patients. Cancer‐derived large extracellular vesicles deliver CYBA (p22phox) to neutrophils, triggering reactive oxygen species (ROS) and citrullinated histone H3 (citH3) formation. This drives neutrophil extracellular traps formation (NETosis), elevating VTE risk.
Xiangji Li+8 more
wiley +1 more source
REFLUX OF THE INTESTINAL CHYLE IN THE LYMPHATICS OF THE LEG
MM. SERVELLE DEYSSON
openalex +2 more sources
In this study, the expression and function of LCN2 in GC is aimed to investigate and elucidate the mechanisms by which the LCN2‐dependent positive‐feedback loop between GC cells and TAMs drives lymphangiogenesis and lymphatic metastasis. These findings suggest that LCN2 may serve as a potential prognostic biomarker and therapeutic target in GC ...
Zhixin Huang+15 more
wiley +1 more source